Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:736585rdf:typepubmed:Citationlld:pubmed
pubmed-article:736585lifeskim:mentionsumls-concept:C0026764lld:lifeskim
pubmed-article:736585lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:736585lifeskim:mentionsumls-concept:C0597032lld:lifeskim
pubmed-article:736585lifeskim:mentionsumls-concept:C0032131lld:lifeskim
pubmed-article:736585lifeskim:mentionsumls-concept:C0221912lld:lifeskim
pubmed-article:736585lifeskim:mentionsumls-concept:C0431085lld:lifeskim
pubmed-article:736585lifeskim:mentionsumls-concept:C2828008lld:lifeskim
pubmed-article:736585pubmed:issue12lld:pubmed
pubmed-article:736585pubmed:dateCreated1979-3-24lld:pubmed
pubmed-article:736585pubmed:abstractTextSolitary cutaneous plasmacytomas may occur as benign tumors that are confined to the skin, whereas multiple lesions are generally associated with systemic plasma cell disease. Cutaneous plasmacytomas developed in two patients with documented multiple myeloma; this development occurred late in the course of their disease at a time when their systemic plasma cell tumor burden was large-approximately 3 kg in mass, which represented 2 to 3 x 10(12) cells. The occurrence of cutaneous plasmacytomas in patients with multiple myeloma is generally late in the course of the disease and should be considered as a bad prognostic sign.lld:pubmed
pubmed-article:736585pubmed:languageenglld:pubmed
pubmed-article:736585pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:736585pubmed:citationSubsetAIMlld:pubmed
pubmed-article:736585pubmed:statusMEDLINElld:pubmed
pubmed-article:736585pubmed:monthDeclld:pubmed
pubmed-article:736585pubmed:issn0003-987Xlld:pubmed
pubmed-article:736585pubmed:authorpubmed-author:AlbertsD SDSlld:pubmed
pubmed-article:736585pubmed:authorpubmed-author:LynchPPlld:pubmed
pubmed-article:736585pubmed:issnTypePrintlld:pubmed
pubmed-article:736585pubmed:volume114lld:pubmed
pubmed-article:736585pubmed:ownerNLMlld:pubmed
pubmed-article:736585pubmed:authorsCompleteYlld:pubmed
pubmed-article:736585pubmed:pagination1784-7lld:pubmed
pubmed-article:736585pubmed:dateRevised2008-3-17lld:pubmed
pubmed-article:736585pubmed:meshHeadingpubmed-meshheading:736585-H...lld:pubmed
pubmed-article:736585pubmed:meshHeadingpubmed-meshheading:736585-S...lld:pubmed
pubmed-article:736585pubmed:meshHeadingpubmed-meshheading:736585-A...lld:pubmed
pubmed-article:736585pubmed:meshHeadingpubmed-meshheading:736585-M...lld:pubmed
pubmed-article:736585pubmed:meshHeadingpubmed-meshheading:736585-M...lld:pubmed
pubmed-article:736585pubmed:meshHeadingpubmed-meshheading:736585-P...lld:pubmed
pubmed-article:736585pubmed:meshHeadingpubmed-meshheading:736585-P...lld:pubmed
pubmed-article:736585pubmed:meshHeadingpubmed-meshheading:736585-N...lld:pubmed
pubmed-article:736585pubmed:meshHeadingpubmed-meshheading:736585-M...lld:pubmed
pubmed-article:736585pubmed:year1978lld:pubmed
pubmed-article:736585pubmed:articleTitleCutaneous plasmacytomas in myeloma. Relationship to tumor cell burden.lld:pubmed
pubmed-article:736585pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:736585pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:736585pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:736585lld:pubmed